Antidiabetic

This page contains recent news articles, when available, and an overview of Antidiabetic but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Novo Nordisk’s Liraglutide Shows Promise against Type 2 Diabetes ...  15 Sep 2008
The study comprised of 533 participants, earlier treated with a single or multiple oral antidiabetic drugs, receiving run-in metformin and rosiglitazoneMedi News Direct,

Gain a Pipeline Insight into Insulin Antidiabetics: Alternative ...  Sep 8, 2008
Comprehensive analysis of the current insulin antidiabetic pipeline detailing the broad range of developmental classes. - A detailed clinical and commercialMarketWatch

Novartis presents new drug data  Sep 11, 2008
New data show Galvus – an oral dipeptidyl peptidase 4 (DPP-4) inhibitor for type 2 diabetes – can lower blood sugar without the risk of producingPharmacy Europe,

Forecast Insight - Antidiabetics - Switching to new molecule ...  Sep 12, 2008
The glitazone class was the major non-insulin antidiabetic therapy in 2007 driven by the Actos and Avandia franchises. Both of these drugs will lose theirPR-Inside.com (Pressemitteilung),

Rosiglitazone Discontinuation May Interfere With Medication Use ...  Sep 8, 2008
By Jill Stein ROME -- September 8, 2008 -- Many patients who discontinued their rosiglitazone as a result of recent reports that the oral antidiabetic mightDG News

Exenatide once a week just as effective as twice daily for ...  Sep 9, 2008
Patients could be on either no other antidiabetic drug or one or more oral agents. At 30 weeks, Drucker et al reported that patients taking the once-a-weekTheHeart.Org,

Sanofi Aventis : New Study Results Support the "Basal Plus ...  Sep 10, 2008
The ELEONOR study also confirmed that in a large proportion of patients with secondary failure to oral antidiabetic agents, both Telecare and standard bloodFOXBusiness

USFDA Med-Watch: Byetta Alert  Aug 20, 2008
Byetta should not be restarted. Consider antidiabetic therapies other than Byetta in patients with a history of pancreatitis.Gather.com,

Poststress Left Ventricular Ejection Fraction is an Independent ...  Sep 13, 2008
Diabetes mellitus was defined as a fasting blood glucose level >140 mg/dL or the need for insulin or oral antidiabetic agents. Follow-up data were collectedRedOrbit,

Insulin Glulisine Boosts Diabetes Control in Patients Not ...  Sep 8, 2008
By Jill Stein ROME -- September 8, 2008 -- Therapy with insulin glulisine with or without oral antidiabetic (OAD) therapy is well tolerated and effective inDG News

Levemir(R) Demonstrates A 24-hour Duration Of Action And ...  Sep 11, 2008
It can be added to oral antidiabetic agents, or used in combination with rapid-acting insulin. Levemir® is available in FlexPen®, a prefilled insulin penMedical News Today (press release),

Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic ...  Sep 9, 2008
...the discovery of the marketed antidiabetic compound vildagliptin, for which he was recognized with the Novartis Distinguished Scientist Award in 2000.MarketWatch

A list of drugs that may trip you up  Sep 9, 2008
Antidiabetic agents, which can lead to hypoglycemia, which may result in lightheadedness or dizziness. Digoxin (Lanoxin), a cardiac stimulant that has anChicago Tribune,

Integrating traditional and alternative medicine in healthcare  Sep 9, 2008
...ranging from anti-cancer, anti-asthma, antidiabetic, anti-hypertensives and many others which owe their origin to traditional medicine.IPPmedia,

Novo Nordisk New Data From a Phase 3 Study Confirms Clinical ...  Sep 8, 2008
..."In this clinical trial program, liraglutide offers effective glucose lowering as monotherapy or as an add on to other oral antidiabetic therapies whileMarketWatch

Fatal hemolytic anemia associated with Metformin: a case report  Sep 10, 2008
IntroductionMetformin is a widely prescribed biguanide antidiabetic drug that has been implicated as a cause of hemolytic anemia in three previous case7thSpace Interactive (press release),

COMUNICADO: Glucophage(R) Powder for Oral Solution in Sachet ...  Sep 10, 2008
A landmark study, the United Kingdom Prospective Diabetes Study (UKPDS) has shown metformin to be unique in being the only antidiabetic agent to lower bloodEuropa Press (Comunicado de prensa),

Western European Diabetes Market Shows Movement to Exclusive Pill ...  Sep 2, 2008
The proportion of diabetes patients on oral antidiabetic agents (OAA), either exclusively or as part of a combination therapy, has increased to 64 percentMarketWatch

Alzheimer's plaques reduced by diabetes therapy  Sep 9, 2008
49 who had received insulin only, 28 treated with agents other than insulin, and 18 treated with both insulin and oral antidiabetic mediations.HealthCentral.com,

Assessing the Cardiovascular Safety of Diabetes Therapies  Sep 10, 2008
Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf 2007;16:711-725. [CrossRef][ISI][Medline] The ActionNew England Journal of Medicine (subscription),

Posted by Thomas Repas, DO, FACP, FACE, CDE September 5, 2008 01:18 PM  Sep 8, 2008
The question was, which oral antidiabetic and lipid-lowering agents might be options? However, he also had experienced a fragility fracture of the right hipEndocrine Today,

New England Journal of Medicine Publishes Phase III Results of ...  Aug 27, 2008
Patients on oral antidiabetic medication while receiving VELCADE should check blood sugar levels frequently. Safety data from Phase II and III studies ofMarketWatch

Fasting Plasma Glucose Cutoff for Diagnosis of Diabetes in a ...  Sep 4, 2008
Design: Cross-sectional study populations of 2421 subjects in 1988 and 2698 subjects in 2002, aged 40–79 yr and without antidiabetic medication,Journal of Clinical Endocrinology and Metabolism,

Social forestry, exotic trees and monga  Sep 5, 2008
...especially for malaria, and products made from Neem have proven medicinal properties being antihelmintic, antifungal, antidiabetic, antibacterial,The Daily Star,

Nearly Nine Out Of Ten Patients With Type 2 Diabetes Achieve QoF ...  Aug 31, 2008
These results also compare favourably with other combinations of oral antidiabetic treatments such as sitagliptin plus metformin HCL.Medical News Today (press release),

SMBG – Smart management of Diabetes  Aug 28, 2008
In patients taking oral antidiabetic drugs, self-monitoring is very useful where patients are on drugs that might cause hypoglycemia.Merinews,

A-to-Z Buyer's Guide  Aug 26, 2008
For anyone taking antidiabetic medication or insulin, dosages may need to be adjusted by a physician when chromium is taken. CoQ10 (coenzyme Q10) is aRedOrbit,

FDA Reinforces Pancreatitis Warnings Associated with Byetta  Aug 21, 2008
Consider antidiabetic therapies other than Byetta in patients with a history of pancreatitis. Patients taking Byetta should seek immediate medical attentionInjuryBoard.com,

Forecast Insight: Antidiabetics Switching to new molecule ...  Aug 22, 2008
The glitazone class was the major non-insulin antidiabetic therapy in 2007 driven by the Actos and Avandia franchises. Both of these drugs will lose theirPharmaceutical Business Review

Market Report -- In Play (AMLN)  Aug 18, 2008
Consider antidiabetic therapies other than Byetta in patients with a history of pancreatitis. FDA is working with the maker of Byetta,MSN Money

Opportunities for Enhancing the FDA Guidance on Pharmacovigilance  Aug 26, 2008
7 Even if observational studies of intended beneficial drug effects such as the prevention of heart disease by antidiabetic treatments could be designed andJournal of American Medical Association (subscription),

Liraglutide Outperforms Glimepiride as Monotherapy in Type 2 ...  Sep 8, 2008
By Jill Stein ROME -- September 8, 2008 -- Once-daily liraglutide used alone significantly boosts glucose control in patients with type 2 diabetes comparedDG News

Half-yearly report  -  07 Aug 2008
In the first six months of 2008, sales of oral antidiabetic products increased by 14% in local currencies and by 6% in Danish kroner to DKK 1118 million MarketWatch

Pipeline Insight: Non-Insulin Antidiabetics - Incretin Mimetics ...  -  Aug 1, 2008
Comprehensive analysis of the current non-insulin antidiabetic pipeline detailing the broad range of developmental classes. - A detailed clinical and MarketWatch

Research Update  -  Jul 14, 2008
In contrast to most other antidiabetic treatments, liraglutide also leads to weight loss instead of weight increase. Novo Nordisk is a healthcare company MarketWatch

Drug Companies Duping Doctors  -  Jul 22, 2008
Also cardiovascular outcomes like heart attacks and strokes should not be increased with any antidiabetic therapy but data so far are lacking. Evening Bulletin,

Novo Nordisk suspends worker in insider trading probe  -  Jul 29, 2008
...significant improvement in blood sugar control in type-two diabetes patients when compared with glimepiride, a widely-used oral antidiabetic drug. Hays Pharma,

Pipeline Insight: Insulin antidiabetics - Return to injections ...  -  Jul 8, 2008
Comprehensive analysis of the current insulin antidiabetic pipeline detailing the broad range of developmental classes. A detailed clinical and commercial Pharmaceutical Business Review

Excessive and Binge Drinking May Increase Risk for Metabolic Syndrome  -  Aug 4, 2008
...diagnosis of diabetes mellitus or taking antidiabetic medication, increased triglyceride levels, low HDL cholesterol levels, high blood pressure, Medscape (subscription)

Peripheral Arterial Disease: Diagnosis and Management  -  Aug 5, 2008
No controlled trials have directly evaluated the effects of antidiabetic therapy on the natural history of PAD.12,13,37,38 Treatment of Hypertension. RedOrbit,

Discover the Next Generation Treatments and Market Dynamics with ...  -  Jul 18, 2008
Although extended lifecycle management for existing antidiabetic therapies may offer sales growth in the short term, the development of new drugs from novel MarketWatch

Colesevelam Safe, Effective in Patients With Diabetes Receiving ...  -  Jul 29, 2008
...mellitus inadequately controlled (glycated hemoglobin level, 7.5% - 9.5%) with insulin therapy alone or in combination with oral antidiabetic agents. Medscape (subscription)

Paper in Molecular Cancer Therapeutics Reports that a Novel ...  -  Jul 21, 2008
7(7):1871-9) reports that a combination of ONCONASE (ranpirnase) and the thiazolidinedione antidiabetic drug rosiglitazone shows a promising effect for Biloxi Sun Herald,

Growth Inhibition of Human Colon Cancer Cells By Plant Compounds  -  Aug 1, 2008
Subash B, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde-A potential antidiabetic agent. Phytomedicine. 2007;14:15-22. 19. Ali S, Khan A, Ahmed I, RedOrbit,

Nearly Nine Out Of Ten Patients With Type 2 Diabetes Achieve QoF ...  -  Jul 20, 2008
These results also compare favourably with other combinations of oral antidiabetic treatments such as sitagliptin plus metformin HCL. Medical News Today (press release),

Should the FDA Require Cardiovascular Studies for Diabetes ...  -  Jul 10, 2008
...complications in type 2 diabetes has not yet been established for any of the currently available antidiabetic medications, including insulin. About - News & Issues,

District Court Holds Software Transfer Not A License, Okays ...  -  Jul 21, 2008
The district court, ruling before KSR, found that compound b was not an obvious choice to modify to make an antidiabetic because one of its side effects is Mondaq News Alerts (subscription),

Market Report -- In Play (WIRES)  -  Jul 21, 2008
...antidiabetic drug rosiglitazone shows a promising effect for cancers with increased expression of PI3K-dependent Fra-1 expression or Survivin. MSN Money

ACEL: Positive Study Published re ONCONASE(R) w/Rosiglitazone for ...  -  Jul 21, 2008
7(7):1871-9) reports that a combination of ONCONASE(R)(ranpirnase) and the thiazolidinedione antidiabetic drug rosiglitazone shows a promising effect Trading Markets (press release),

Invenţiile românilor  -  Jul 12, 2008
După o pauză pe perioada celui de-al Doilea Război Mondial, Paulescu îşi reia cercetările şi reuşeşte să izoleze hormonul pancreatic antidiabetic Adevărul,

Ce se intampla cand combinam medicamentele cu alcoolul  -  Jul 23, 2008
...tinidazol (cu actiune antimicrobiana si antiparazitara), tolbutamida (antidiabetic) provoaca reactii care se manifesta prin stari de greata, voma, Ziare.com,

Medicamentele si alcoolul: ce riscam cind le combinam  -  Jul 22, 2008
...tolbutamida (antidiabetic) provoaca o reactie de tip antabuz care se manifesta prin stari de greata, voma, vasodilatatie, hipotensiune arteriala, Ziarul de Iasi,

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.